Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Impact of Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Therapy on Dementia and Cognitive Decline
Antonio Lardaro, L. Quarta, Stefania Pagnotta, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1750-1750
Open Access | Times Cited: 19
Diabetes and cognitive function: An evidence-based current perspective
Meghna Julian Sebastian, Shahanas K A Khan, Joseph M Pappachan, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 2, pp. 92-109
Open Access | Times Cited: 39
Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta‐analysis
Alvin Kuate Defo, Veselko Bakula, Alessandro Pisaturo, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 2, pp. 441-462
Open Access | Times Cited: 31
Association of Metformin use with risk of dementia in patients with type 2 diabetes: A systematic review and meta‐analysis
Chunbian Tang, Jiayi Hao, Fengran Tao, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access | Times Cited: 1
Insulin resistance as the molecular link between diabetes and Alzheimer's disease
Mona Mohamed Ibrahim Abdalla
World Journal of Diabetes (2024) Vol. 15, Iss. 7, pp. 1430-1447
Open Access | Times Cited: 8
Polyoxidovanadates a new therapeutic alternative for neurodegenerative and aging diseases
Sonia Irais González‐Cano, Gonzalo Flores, Jorge Guevara, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 3, pp. 571-577
Open Access | Times Cited: 12
Early life interventions metformin and trodusquemine metabolically reprogram the developing mouse liver through transcriptomic alterations
Sarah Ashiqueali, Augusto Schneider, Xiang Zhu, et al.
Aging Cell (2024) Vol. 23, Iss. 9
Open Access | Times Cited: 4
Hesperetin-Enhanced Metformin to Alleviate Cognitive Impairment via Gut–Brain Axis in Type 2 Diabetes Rats
Danyang Zhang, Xiaoshi He, Yinbo Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1923-1923
Open Access
Risk Factors, Pathological Changes, and Potential Treatment of Diabetes‐Associated Cognitive Dysfunction
Xiangkuan Meng, Haiyang Du, Danpei Li, et al.
Journal of Diabetes (2025) Vol. 17, Iss. 4
Open Access
Metformin and Cognitive Performance in Patients With Type 2 Diabetes: An Umbrella Review
Athena Enderami, Behnam Shariati, Mehran Zarghami, et al.
Neuropsychopharmacology Reports (2025) Vol. 45, Iss. 1
Open Access
Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis
Esther K. Hui, Naaheed Mukadam, Gianna Kohl, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Postmortem Brains from Subjects with Diabetes Mellitus Display Reduced GLUT4 Expression and Soma Area in Hippocampal Neurons: Potential Involvement of Inflammation
Caio Yogi Yonamine, Marisa Passarelli, Cláudia Kimie Suemoto, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1250-1250
Open Access | Times Cited: 8
Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration
Jason Xiao, Wendy Luo, Amir Mani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11357-11357
Open Access | Times Cited: 3
Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
Jiayu Zhang, Xuejing Ma, Fuwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Cognitive impairment in type 2 diabetes mellitus: prospects for the use of metformin
N.V. Pashkovska
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2023) Vol. 19, Iss. 3, pp. 215-224
Open Access | Times Cited: 6
Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health
Raj N. Kalaria, Rufus Akinyemi, Stella‐Maria Paddick, et al.
Expert Review of Neurotherapeutics (2023) Vol. 24, Iss. 1, pp. 25-44
Open Access | Times Cited: 6
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease
C. H. Anderson, Magda Bucholc, Paula L. McClean, et al.
Biomolecules (2023) Vol. 14, Iss. 1, pp. 11-11
Open Access | Times Cited: 6
Assessment of Cognitive Flexibility in Jordanian Diabetic Patients by Wisconsin Card Sorting and Trail Making Tests: Implications with Demographic, Anthropometric and Therapeutic Variables
Shaimaa Nasr Amin, Gehan El-Akabawy, Mohammad Abuqasem, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 2655-2670
Open Access | Times Cited: 1
The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis
Tzu‐Rong Peng, Jou-An Chen, Jen‐Ai Lee, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
The relationship between metformin administration and age-related macular degeneration; a systematic review and meta-analysis of observational studies
Abdulateef A. Mashaf, Mohammed Abdul-Mounther Othman, Omer Mansib Kassid, et al.
Journal of Nephropharmacology (2024) Vol. 13, Iss. 2, pp. e12690-e12690
Open Access
Modern views on pathogenesis of cognitive impairment in patients with type 2 diabetes mellitus
T. Yu. Demidova, A. S. Teplova, V. O. Yarmanova
Meditsinskiy sovet = Medical Council (2024), Iss. 16, pp. 265-273
Open Access
Page 1

Scroll to top